Goldman Sachs’s DTRT Health Acquisition Corp. Class A Common Stock DTRT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-26,830
Closed -$273K 6427
2022
Q3
$273K Sell
26,830
-331,326
-93% -$3.35M ﹤0.01% 5341
2022
Q2
$3.6M Buy
358,156
+344,228
+2,471% +$3.46M ﹤0.01% 3495
2022
Q1
$140K Buy
+13,928
New +$139K ﹤0.01% 5998

Other funds holding DTRT

Goldman Sachs's DTRT Position: Q4 2022 in Review

Goldman Sachs sold out of DTRT Health Acquisition Corp. Class A Common Stock (DTRT) in Q4 2022, closing a stake of 26,830 shares — an estimated $273K sold.

Goldman Sachs first reported a position in DTRT in Q1 2022 and held it in 3 quarters. The position peaked at $3.6M in Q2 2022. 17 funds tracked by Wall St. Rank hold DTRT as of Q4 2022.

  • Goldman Sachs reported no remaining DTRT Health Acquisition Corp. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
  • Goldman Sachs sold 26,830 DTRT Health Acquisition Corp. Class A Common Stock shares in Q4 2022, an estimated $273K.
  • Goldman Sachs first reported a position in DTRT Health Acquisition Corp. Class A Common Stock in Q1 2022 and held it in 3 quarters.
  • Goldman Sachs's DTRT Health Acquisition Corp. Class A Common Stock position peaked at $3.6M in Q2 2022.
  • 17 funds tracked by Wall St. Rank held DTRT Health Acquisition Corp. Class A Common Stock as of Q4 2022.

Based on Goldman Sachs's 13F filing for Q4 2022, filed 13 Feb 2023.